1. Up Front

   Up Front 24 June 2021 Pages: 1707 - 1708

   

2. Youth-onset type 2 diabetes: translating epidemiology into clinical trials

   • Laura Pyle
   • Megan M. Kelsey

   Review 01 June 2021 Pages: 1709 - 1716

   

3. A UK nationwide study of people with type 1 diabetes admitted to hospital with COVID-19 infection

   • Yue Ruan
   • Robert E. J. Ryder
   • on behalf of the ABCD Covid-19 audit group

   Article Open access 08 May 2021 Pages: 1717 - 1724

   

4. Continuous subcutaneous insulin infusion therapy is associated with reduced retinopathy progression compared with multiple daily injections of insulin

   • Laura J. Reid
   • Fraser W. Gibb
   • Shareen Forbes

   Article Open access 08 May 2021 Pages: 1725 - 1736

   

5. Acute hyperglycaemia does not have a consistent adverse effect on exercise performance in recreationally active young people with type 1 diabetes: a randomised crossover in-clinic study

   • Karen M. Rothacker
   • Sam Armstrong
   • Elizabeth A. Davis

   Article 04 May 2021 Pages: 1737 - 1748

   

6. Markers of metabolic health and gut microbiome diversity: findings from two population-based cohort studies

   • Semi Zouiouich
   • Erikka Loftfield
   • Marc J. Gunter

   Article Open access 10 June 2021 Pages: 1749 - 1759

   

7. Long-term metformin use and risk of pneumonia and related death in type 2 diabetes: a registry-based cohort study

   • Aimin Yang
   • Mai Shi
   • Elaine Chow

   Short Communication 12 April 2021 Pages: 1760 - 1765

   

8. Early-life exposure to the Chinese famine, genetic susceptibility and the risk of type 2 diabetes in adulthood

   • Bin Wang
   • Jing Cheng
   • Yingli Lu

   Article 22 April 2021 Pages: 1766 - 1774

   

9. Comparison of the contributions of impaired beta cell function and insulin resistance to the development of type 2 diabetes in a Japanese community: the Hisayama Study

   • Masahito Yoshinari
   • Yoichiro Hirakawa
   • Toshiharu Ninomiya

   Article 28 April 2021 Pages: 1775 - 1784

   

10. The oxylipin profile is associated with development of type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY)

    • Teresa Buckner
    • Lauren A. Vanderlinden
    • Jill M. Norris

    Article 24 April 2021 Pages: 1785 - 1794

    

11. Physical activity attenuates postprandial hyperglycaemia in homozygous TBC1D4 loss-of-function mutation carriers

    • Theresia M. Schnurr
    • Emil Jørsboe
    • Torben Hansen

    Article Open access 29 April 2021 Pages: 1795 - 1804

    

12. Genetic predisposition in the 2′-5′A pathway in the development of type 1 diabetes: potential contribution to dysregulation of innate antiviral immunity

    • Kristina Pedersen
    • Martin Haupt-Jorgensen
    • Karsten Buschard

    Article Open access 11 May 2021 Pages: 1805 - 1815

    

13. Reduced beta cell number rather than size is a major contributor to beta cell loss in type 2 diabetes

    • Hironobu Sasaki
    • Yoshifumi Saisho
    • Hiroshi Itoh

    Short Communication Open access 03 May 2021 Pages: 1816 - 1821

    

14. Peripheral immune circadian variation, synchronisation and possible dysrhythmia in established type 1 diabetes

    • Craig A. Beam
    • Eleni Beli
    • Linda A. DiMeglio

    Article Open access 18 May 2021 Pages: 1822 - 1833

    

15. Dapagliflozin reduces thrombin generation and platelet activation: implications for cardiovascular risk reduction in type 2 diabetes mellitus

    • Christina Kohlmorgen
    • Stephen Gerfer
    • Maria Grandoch

    Article Open access 16 June 2021 Pages: 1834 - 1849

    

16. HAND2 is a novel obesity-linked adipogenic transcription factor regulated by glucocorticoid signalling

    • Maude Giroud
    • Foivos-Filippos Tsokanos
    • Stephan Herzig

    Article Open access 20 May 2021 Pages: 1850 - 1865

    

17. Adiponectin receptor agonist AdipoRon ameliorates renal inflammation in diet-induced obese mice and endotoxin-treated human glomeruli ex vivo

    • Sonja Lindfors
    • Zydrune Polianskyte-Prause
    • Sanna Lehtonen

    Article Open access 14 May 2021 Pages: 1866 - 1879

    

18. Greater daily glucose variability and lower time in range assessed with continuous glucose monitoring are associated with greater aortic stiffness: The Maastricht Study

    • Yuri D. Foreman
    • William P. T. M. van Doorn
    • Coen D. A. Stehouwer

    Article Open access 15 May 2021 Pages: 1880 - 1892

    

19. Does nocturnal hypoglycaemia really improve quality of life?

    • Uffe Søholm
    • Melanie M. Broadley
    • Frans Pouwer

    Letter 20 May 2021 Pages: 1893 - 1894

20. Does nocturnal hypoglycaemia really improve quality of life? Reply to Søholm U, Broadley MM, Choudhary P et al [letter]

    • Marie M. Henriksen
    • Henrik U. Andersen
    • Ulrik Pedersen-Bjergaard

    Letter 17 June 2021 Pages: 1895 - 1896

21. ADHD should be considered in adolescents with type 1 diabetes and poor metabolic control

    • Charlotte Nylander
    • Elisabeth Fernell

    Letter 09 June 2021 Pages: 1897 - 1898

22. Correction to: Acute hyperglycaemia does not have a consistent adverse effect on exercise performance in recreationally active young people with type 1 diabetes: a randomised crossover in-clinic study

    • Karen M. Rothacker
    • Sam Armstrong
    • Elizabeth A. Davis

    Correction 11 June 2021 Pages: 1899 - 1899

23. Correction to: Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study

    • Linong Ji
    • Ying Du
    • Lei Chen

    Correction Open access 26 May 2021 Pages: 1900 - 1901